Phibro Animal Health Partners with Lighthouse Pharmaceuticals for Canine Dental Care

October 9, 2025 - 20:08

TEANECK, N.J., October 09, 2025—Phibro Animal Health Corporation, a prominent player in the animal health and nutrition sector, has revealed a significant licensing agreement with Lighthouse Pharmaceuticals, Inc. This collaboration focuses on a groundbreaking therapeutic asset designed to enhance periodontal health in dogs.

Periodontal disease is a common issue among dogs, leading to serious health complications if left untreated. This innovative asset aims to address these concerns by promoting better oral health and preventing the progression of dental diseases in companion animals. The agreement underscores Phibro's commitment to advancing veterinary care and improving the quality of life for pets.

With this partnership, both companies are poised to leverage their expertise and resources to bring effective solutions to the market. As pet owners increasingly seek ways to ensure their animals' health and well-being, this new development could play a pivotal role in canine dental care, marking a significant step forward in veterinary medicine.